Last updated on December 2019

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Brief description of study

The goal for this study is to evaluate the efficacy and safety of tirzepatide versus placebo in participants with type 2 diabetes not under control with diet and exercise alone. The study will last approximately 47 weeks and may include about 15 visits.

Clinical Study Identifier: NCT03954834

Find a site near you

Start Over

Minamiakatsuka Clinic

Mito, Japan
  Connect »